What are the side effects of stopping Artane (trihexyphenidyl)?

Withdrawal Effects of Artane (Trihexyphenidyl)

Abrupt discontinuation of Artane (trihexyphenidyl) causes a recognizable withdrawal syndrome characterized by increased anxiety, physical complaints, orthostatic hypotension, tachycardia, and temporary worsening of both extrapyramidal symptoms and psychotic symptoms. 1

Documented Withdrawal Symptoms

Cardiovascular and Autonomic Effects

• Orthostatic hypotension (drop in blood pressure upon standing) occurs following trihexyphenidyl withdrawal 1
• Tachycardia (rapid heart rate) develops as part of the withdrawal syndrome 1
• These autonomic symptoms indicate physiologic dependence has developed with chronic use 1

Psychiatric and Neurological Manifestations

• Increased anxiety is a hallmark feature of trihexyphenidyl withdrawal 1
• Various physical complaints emerge during the discontinuation period 1
• Temporary deterioration in psychotic symptoms may occur, particularly in patients on concurrent antipsychotic medications 1

Movement Disorder Exacerbation

• Temporary worsening of extrapyramidal symptoms (EPS) occurs after stopping trihexyphenidyl 1
• In patients with severe segmental cranial dystonia, life-threatening exacerbation can occur with abrupt withdrawal, including severe cranial dystonia, inspiratory stridor, and acute respiratory difficulties 2
• Forward neck bending combined with mouth-clenching spasms can cause upper airway obstruction 2

Critical Safety Considerations

High-Risk Populations

• Patients with severe cranial dystonia are at particular risk for dangerous withdrawal reactions, even when no obvious benefit from the medication is apparent 2
• Elderly patients may experience more severe anticholinergic rebound effects given their baseline sensitivity 3

Time Course of Withdrawal

• Most withdrawal parameters eventually return to baseline values, indicating symptoms are directly related to trihexyphenidyl discontinuation rather than underlying disease progression 1
• The duration of withdrawal symptoms varies but typically resolves over days to weeks 1

Safe Discontinuation Strategy

Gradual Tapering Protocol

• Never discontinue trihexyphenidyl abruptly, especially in patients with severe dystonia or those on long-term therapy 2
• Gradual withdrawal over an extended period is recommended to minimize discontinuation effects, similar to recommendations for other anticholinergic medications 4
• If severe withdrawal symptoms develop, reinstitution of anticholinergic medication (including intravenous administration in emergencies) provides relatively prompt relief 2

Monitoring During Discontinuation

• Monitor for cardiovascular instability, particularly orthostatic blood pressure changes and heart rate 1
• Assess for anxiety and psychological distress throughout the tapering process 1
• Watch for worsening of underlying movement disorder or EPS 1
• In patients with dystonia, monitor for respiratory compromise from exacerbated cranial or cervical dystonia 2

Common Pitfalls to Avoid

• Do not assume lack of obvious benefit means withdrawal will be benign - even patients showing no apparent response to trihexyphenidyl can experience severe withdrawal reactions 2
• Do not discontinue abruptly in any patient, regardless of dose or duration of therapy 1, 2
• Do not mistake withdrawal symptoms for disease progression - recognize that anxiety, autonomic instability, and temporary EPS worsening are withdrawal-related 1